Skip to Content

Patrys Ltd PATLF Stock Quote

| Rating as of


  • Last Close 0.04
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Value
  • Day Range  – 
  • Year Range  – 
  • Market Cap
  • Volume / Avg  / 
  • Price / Sales 3,235.73
  • Price / Book 9.39
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis PATLF

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics PATLF

Company Profile PATLF

Business Description

Patrys Ltd focuses on the development of natural human antibody-based therapies for the treatment of cancer. The company's product includes Deoxymab 3E10, PAT-SC1, PAT-DX1 and PAT-DX1-NP, PAT-DX3 and PAT-LM1. Its lead technology is Deoxymab 3E10, a DNA damage repair (DDR) antibody which penetrates live cell nuclei and inhibits key mechanisms of DNA repair in target cancer cells.

Level 4, 100 Albert Road, South Melbourne
Melbourne, VIC, 3205, AUS
Industry Biotechnology
Employees 23

Competitors & Peers PATLF

Morningstar does not cover competitors or peers for this firm.

FAQs for Patrys Ltd Stock

No. PATLF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

PATLF’s stock style is Small Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

PATLF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare PATLF’s historical performance against its industry peers and the overall market.